Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Clinical trial NCT01151215 · TERMINATED

Trial details

NCT number: NCT01151215
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Breast Neoplasms Breast Cancer

Start date: 2010-06-01
Primary completion: 2013-01-01
Enrollment: 482

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.